The New GCR Quarterly: Intellectual Property: Download now

Anti-monopoly enforcement is not all about case counts, says FTC official

Spring break: The Tipline for 15 March 2019

Cities’ sulfate suit survives motions to dismiss

No more no-poach: The Tipline for 14 March 2019

Year in preview: antitrust on a “blue wave”

For the first time in eight years, Democrats control the US House of Representatives and its antitrust subcommittee. With that comes a bully pulpit, but also a big stick of investigation and potentially legislation.

Q&A with Cleary’s Kathleen Bradish

Kathleen Bradish returned to Cleary Gottlieb Steen & Hamilton as counsel last autumn after almost three-and-a-half years at the Department of Justice’s antitrust division, where she was assistant chief for the international section. She already had nearly a decade of experience at Cleary, where she represented pharmaceutical companies including Santarus, Abbott Laboratories and GlaxoSmithKline. Bradish will be speaking at the inaugural GCR Live Pharmaceuticals conference on 28 February in Washington, DC.

Litigators of the Week: White & Case

The overturning of class certification for indirect purchasers of Asacol may reshape how some class actions are formed, as a defence strategy of aggressive discovery on plaintiffs bore fruit in a successful appeal.

Hot Docs – Hovenkamp, hospital-home bias and a healthy dose of judicial review

While the recent heatwave may have you inside by the air-conditioning all day, we have collected the hottest docs in antitrust to keep you entertained.